Assaf Marcus
VP Translational Science at Edity Therapeutics- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Rehovot, Center District, Israel, IL
Languages
-
Hebrew Native or bilingual proficiency
-
English Native or bilingual proficiency
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Edity Therapeutics
-
Israel
-
Biotechnology Research
-
1 - 100 Employee
-
VP Translational Science
-
May 2022 - Present
-
-
Head of Preclinical
-
Oct 2021 - Jun 2022
-
-
-
AbbVie
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Scientist
-
Nov 2019 - Oct 2021
In charge of developing novel CAR T cell therapies In charge of developing novel CAR T cell therapies
-
-
-
University of California, Berkeley
-
United States
-
Higher Education
-
700 & Above Employee
-
Specialist
-
Sep 2014 - Jul 2019
Investigated the role of the cGAS/STING pathway in inducing NK and T cell responses against tumors
-
-
Postdoctoral Researcher
-
2011 - Sep 2014
Investigated NK cell memory
-
-
-
Weizmann Institute of Science
-
Israel
-
Research
-
700 & Above Employee
-
PHD Student
-
2004 - 2010
Devised strategies to employ allogeneic CAR T cells as a standardized cellular treatment of cancer under the tutelage of Prof. Zelig Eshhar Devised strategies to employ allogeneic CAR T cells as a standardized cellular treatment of cancer under the tutelage of Prof. Zelig Eshhar
-
-
Education
-
2004 - 2010
The Weizmann Institute of Science
Doctor of Philosophy (Ph.D.), Immunology -
2000 - 2003
The Hebrew University
Bachelor’s Degree, Computer Science and computational biology
Community
You need to have a working account to view this content.
Click here to join now
